SKU: SLU-PP-332 250mcg & 5-AMINO-1MQ 50mg
Why its notable: human trials show that CJC-1295 raises growth hormone (GH) and insulin-like growth factor (IGF-1) levels in controlled settings, when used with appropriate supervision
There have been postmarketing reports of renal impairment, acute kidney injury, and worsening of chronic renal failure, which sometimes has required hemodialysis, in patients treated with GLP-1 receptor agonists
Affiliate program 20% commission Refer researchers, clinics & creators earn 20% on first-month orders
"Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application"
This can actually help prevent the gaunt look sometimes associated with rapid weight loss